Pyrimidinecarboxamide derivatives as inhibitors of Syk kinase

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The Glaxo Group Limited patent solves the following problem:

Our analysis of this patent is as follows:

Glaxo Group Limited’s patent US 8470835 B2 deals with Pyrimidinecarboxamide derivatives as inhibitors of Syk kinase.
The present invention relates to a compound of formula (I): or a salt, preferably a pharmaceutically acceptable salt thereof; is an inhibitor of spleen tyrosine kinase (SYK) and therefore potential use in the treatment of diseases that result in inappropriate activation of mast cell, for example, allergic and inflammatory diseases, as well as the potential use of cancer therapy, especially heme malignancies.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.